Generic name:meningococcal conjugate vaccine [ me-NIN-je-KOK-al-KON-je-gate-vax-EEN ]
Brand names: Menactra, MenQuadfi, Menveo
What is MenQuadfi?
Meningococcal disease is a bacterial infection that can infect the spinal cord and brain and cause meningitis, which can be fatal or lead to permanent and disabling medical problems.
Meningococcal disease spreads from person to person through small droplets of saliva expelled into the air when an infected person coughs or sneezes. The bacteria is usually passed through close contact with an infected person, especially through kissing or sharing a drinking glass or eating utensil.
MenQuadfi is used to prevent infection caused by serogroups A, C, W, and Y. This vaccine helps your body develop immunity to meningitis, but will not treat an active infection you already have.
The Menactra brand of this vaccine is for use in children and adults between the ages of 9 months and 55 years old. Menveo is for children and adults between the ages of 2 months and 55 years old. MenQuadfi is for adults and children at least 2 years old.
Like any vaccine, MenQuadfi may not provide protection from disease in every person.
Warnings
You should not receive a booster vaccine if you had a life threatening allergic reaction after the first shot.
Before taking this medicine
You may not be able to receive this vaccine if you've ever had an allergic reaction to a meningococcal, diphtheria, or tetanus vaccine.
This vaccine may need to be postponed or not given at all if you have:
a seve...
